Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 12,895 followers.

RT @NeumologiaPeru: 🔥🔥Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK #COPD Population: The #INTREPID Trial 🫁📚…

RT @NeumologiaPeru: 🔥🔥Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK #COPD Population: The #INTREPID Trial 🫁📚…

RT @NeumologiaPeru: 🔥🔥Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK #COPD Population: The #INTREPID Trial 🫁📚…

🔥🔥Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK #COPD Population: The #INTREPID Trial 🫁📚🩺🔑🏅🎯 ➡️https://t.co/jaXKVALSyc @ERSpublications @NeumoMadrid @ALATorax @RespirologyAPSR https://t.co/CNCnhs4N3p